novo nordisk semaglutide vial hiked annual profit guidance on Tuesday, as the pharmaceutical group revealed sales that beat expectations in the first three months of the year. ➡️ The quarter was the first period Novo to Follow Lilly and

Based on findings from the STEP research team, who compared the drug's impact with a placebo, it's estimated that 90% of patients receiving Wegovy will manifest a positive response in the preliminary phase (a minimum of 5% weight loss within 5 months).The projected average weight loss hovers around 20% following 68 weeks of administration

: 2 : 4 -

Interestingly, curves in both groups are of the same shape, but with the statistically significant difference- higher numbers of positive vascular elements in the BPC 157 treated group

Stick to natural sugars found in whole fruits, which come packaged with fiber to slow absorption